 | Up a level |
Number of items: 1.
Wolf, J., Oh, I-J., Mazieres, J., de Castro, J., Revil, C., Kotb, A., Johansdottir, H., Zeaiter, A. and Novello, S. (2016). ALUR: a phase 3 study of alectinib versus chemotherapy in previously treated ALK plus non-small cell lung cancer (NSCLC). Ann. Oncol., 27. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041